{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T22:09:20Z","timestamp":1782425360685,"version":"3.54.5"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,1,13]],"date-time":"2022-01-13T00:00:00Z","timestamp":1642032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:title>Graphical Abstract<\/jats:title><jats:p\/>","DOI":"10.3389\/fmicb.2021.788741","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T08:13:28Z","timestamp":1667549608000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Interleukin-37: A Link Between COVID-19, Diabetes, and the Black Fungus"],"prefix":"10.3389","volume":"12","author":[{"given":"Sima","family":"Tokajian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgi","family":"Merhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charbel","family":"Al Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georges","family":"Nemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007098","article-title":"The Role of Interleukin-1 cytokine family (IL-1\u03b2, IL-37) and interleukin-12 cytokine family (IL-12, IL-35) in eumycetoma infection pathogenesis.","volume":"13","author":"Abushouk","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mgene.2021.100989","article-title":"Interleukin-37 gene polymorphism and susceptibility to coronavirus disease 19 among Iraqi patients.","volume":"31","author":"Ahmed","year":"","journal-title":"Meta Gene"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155702","article-title":"Interleukin-37 is down-regulated in serum of patients with severe coronavirus disease 2019 (COVID-19).","volume":"148","author":"Ahmed","year":"","journal-title":"Cytokine"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1080\/08830185.2019.1677644","article-title":"The potential role of interleukin-37 in infectious diseases: role of IL-37 in HIV-1, viral myocarditis, HCV, HBV, tuberculosis, leprosy, pneumonia, listeria, aspergillosis, candidiasis, and eumycetoma infection.","volume":"39","author":"Allam","year":"2020","journal-title":"Int. Rev. Immunol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/FJC.0000000000000476","article-title":"IL-37 ameliorates coxsackievirus B3-induced viral myocarditis by modulating the Th17\/Treg immune response.","volume":"69","author":"An","year":"2017","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"B6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms5711","article-title":"IL-37 protects against obesity-induced inflammation and insulin resistance.","volume":"5","author":"Ballak","year":"2014","journal-title":"Nat. Commun."},{"key":"B7","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1096\/fj.03-0483fje","article-title":"A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development.","volume":"18","author":"Bar","year":"2004","journal-title":"FASEB J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles prize lecture 2005.","volume":"148","author":"Barnes","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1684\/ecn.2011.0288","article-title":"IL-37: a new anti-inflammatory cytokine of the IL-1 family.","volume":"22","author":"Boraschi","year":"2011","journal-title":"Eur. Cytokine Netw."},{"key":"B10","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1073\/pnas.1324140111","article-title":"Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses.","volume":"111","author":"Bulau","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1006\/geno.2000.6184","article-title":"Identification and gene organization of three novel members of the IL-1 family on human chromosome 2.","volume":"66","author":"Busfield","year":"2000","journal-title":"Genomics"},{"key":"B12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by corticosteroids.","volume":"17","author":"Cain","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.94253","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis.","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1111\/imr.12605","article-title":"Suppression of inflammation and acquired immunity by IL-37.","volume":"281","author":"Cavalli","year":"2018","journal-title":"Immunol. Rev."},{"key":"B15","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jinf.2021.03.002","article-title":"Short durations of corticosteroids for hospitalised COVID-19 patients are associated with a high readmission rate.","volume":"82","author":"Chaudhry","year":"2021","journal-title":"J. Infect."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1128\/iai.38.3.1123-1129.1982","article-title":"Generation of chemotactic factors by Rhizopus oryzae in the presence and absence of serum: relationship to hyphal damage mediated by human neutrophils and effects of hyperglycemia and ketoacidosis.","volume":"38","author":"Chinn","year":"1982","journal-title":"Infect. Immun."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9 (th) edition.","volume":"157","author":"Colagiuri","year":"2019","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (Interleukin-1 and Interleukin-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies.","volume":"34","author":"Conti","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.609470","article-title":"Type 2 diabetes mellitus and COVID-19: a narrative review.","volume":"12","author":"Corrao","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(SICI)1096-9136(199701)14:1&lt;29::AID-DIA300&gt;3.0.CO;2-V","article-title":"Impaired leucocyte functions in diabetic patients.","volume":"14","author":"Delamaire","year":"1997","journal-title":"Diabetic Med."},{"key":"B21","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/iai.38.1.292-297.1982","article-title":"Monocyte-mediated damage to Rhizopus oryzae hyphae in vitro.","volume":"38","author":"Diamond","year":"1982","journal-title":"Infect. Immun."},{"key":"B22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.smim.2013.10.004","article-title":"Interleukin-37.","volume":"25","author":"Dinarello","year":"2013","journal-title":"Semin. Immunol."},{"key":"B23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease.","volume":"11","author":"Donath","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02028","article-title":"More than suppression: glucocorticoid action on monocytes and macrophages.","volume":"10","author":"Ehrchen","year":"2019","journal-title":"Front. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.2337\/dbi20-0022","article-title":"Managing hyperglycemia in the COVID-19 inflammatory storm.","volume":"69","author":"Gianchandani","year":"2020","journal-title":"Diabetes"},{"key":"B26","doi-asserted-by":"publisher","first-page":"461S","DOI":"10.1093\/ajcn\/83.2.461S","article-title":"Obesity and the role of adipose tissue in inflammation and metabolism.","volume":"83","author":"Greenberg","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"B27","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical characteristics of coronavirus disease 2019 in China.","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"B28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.mmcr.2020.05.008","article-title":"A case of invasive pulmonary mucormycosis resulting from short courses of corticosteroids in a well-controlled diabetic patient.","volume":"29","author":"Hoang","year":"2020","journal-title":"Med. Mycol. Case Rep."},{"key":"B29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor.","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study.","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"B31","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108125","article-title":"COVID-19 and diabetes: can DPP4 inhibition play a role?","volume":"162","author":"Iacobellis","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"B32","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJM199912163412507","article-title":"Infections in patients with diabetes mellitus.","volume":"341","author":"Joshi","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23595","article-title":"Sars-cov-2 infection presenting with hyperglycemia and ketosis: a case series of three diabetic patients.","volume":"24","author":"Kayina","year":"2020","journal-title":"Indian J. Crit. Care Med."},{"key":"B34","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1210\/jc.2004-0395","article-title":"Adipose tissue as an endocrine organ.","volume":"89","author":"Kershaw","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B35","doi-asserted-by":"publisher","first-page":"3023","DOI":"10.1002\/jmv.26837","article-title":"Diabetes predicts severity of COVID-19 infection in a retrospective cohort: a mediatory role of the inflammatory biomarker C-reactive protein.","volume":"93","author":"Koh","year":"2021","journal-title":"J. Med. Virol."},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmicr.2021.100057","article-title":"Mucormycosis in COVID-19 pandemic: risk factors and linkages.","volume":"2","author":"Kumar","year":"2021","journal-title":"Curr. Res. Microb. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"10308","DOI":"10.1074\/jbc.275.14.10308","article-title":"Identification and initial characterization of four novel members of the interleukin-1 family.","volume":"275","author":"Kumar","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.630767","article-title":"Clinical implications of IL-32, IL-34 and IL-37 in atherosclerosis: speculative role in cardiovascular manifestations of COVID-19.","volume":"8","author":"Law","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/infdis\/jiaa713","article-title":"Correlation between early plasma interleukin 37 responses with low inflammatory cytokine levels and benign clinical outcomes in severe acute respiratory syndrome coronavirus 2 infection.","volume":"223","author":"Li","year":"2021","journal-title":"J. Infect. Dis."},{"key":"B40","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1089\/jir.2013.0001","article-title":"Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.","volume":"33","author":"Li","year":"2013","journal-title":"J. Interferon Cytokine Res."},{"key":"B41","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.molimm.2019.06.008","article-title":"Interleukin-37 sensitize the elderly type 2 diabetic patients to insulin therapy through suppressing the gut microbiota dysbiosis.","volume":"112","author":"Li","year":"2019","journal-title":"Mol. Immunol."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection.","volume":"18","author":"Liu","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","article-title":"C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus.","volume":"286","author":"Manson","year":"2001","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1006\/bbrc.1997.6665","article-title":"Interleukin-18 activates NF-\u03baB in murine T helper type 1 cells.","volume":"234","author":"Matsumoto","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-86452-3","article-title":"Symptoms and syndromes associated with SARS-CoV-2 infection and severity in pregnant women from two community cohorts.","volume":"11","author":"Molteni","year":"2021","journal-title":"Sci. Rep."},{"key":"B46","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.1944","article-title":"IL-37 is a fundamental inhibitor of innate immunity.","volume":"11","author":"Nold","year":"2010","journal-title":"Nat. Immunol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/cyto.2000.0799","article-title":"IL-1H, an interleukin 1-related protein that binds IL-18 receptor\/IL-1Rrp.","volume":"13","author":"Pan","year":"2001","journal-title":"Cytokine."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.02482","article-title":"Interleukin-37 ameliorates influenza pneumonia by attenuating macrophage cytokine production in a MAPK-dependent manner.","volume":"10","author":"Qi","year":"2019","journal-title":"Front. Microbiol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsps.2020.12.001","article-title":"Self-medication practices during the COVID-19 pandemic among the adult population in Peru: a cross-sectional survey.","volume":"29","author":"Quispe-Ca\u00f1ari","year":"2021","journal-title":"Saudi Pharm. J."},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01446","article-title":"The COVID-19 cytokine storm; what we know so far.","volume":"11","author":"Ragab","year":"2020","journal-title":"Front. Immunol."},{"key":"B51","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/cid\/cir867","article-title":"Healthcare-associated mucormycosis.","volume":"54","author":"Rammaert","year":"","journal-title":"Clin. Infect. Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.diabet.2012.01.002","article-title":"Diabetes and mucormycosis: a complex interplay.","volume":"38","author":"Rammaert","year":"","journal-title":"Diabetes Metab."},{"key":"B53","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.mpmed.2017.09.007","article-title":"Systemic fungal infections.","volume":"45","author":"Rautemaa-Richardson","year":"2021","journal-title":"Medicine"},{"key":"B54","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMoa1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2 diabetes.","volume":"379","author":"Rawshani","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with Covid-19.","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.629933","article-title":"Why is COVID-19 more severe in patients with diabetes? The role of angiotensin-converting enzyme 2, endothelial dysfunction and the immunoinflammatory system.","volume":"7","author":"Roberts","year":"2020","journal-title":"Front. Cardiovasc. Med."},{"key":"B57","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases.","volume":"41","author":"Roden","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"B58","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.4049\/jimmunol.180.8.5477","article-title":"The IL-1 family member 7b translocates to the nucleus and down-regulates proinflammatory cytokines.","volume":"180","author":"Sharma","year":"2008","journal-title":"J. Immunol."},{"key":"B59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jjcc.2017.02.006","article-title":"The role of adipokines in cardiovascular disease.","volume":"70","author":"Shibata","year":"2017","journal-title":"J. Cardiol."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/jof6040265","article-title":"Epidemiology and diagnosis of mucormycosis: an update.","volume":"6","author":"Skiada","year":"2020","journal-title":"J. Fungi"},{"key":"B61","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2310\/7070.2005.34607","article-title":"Mucormycosis in immunocompetent individuals: an increasing trend.","volume":"34","author":"Sridhara","year":"2005","journal-title":"J. Otolaryngol."},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.696605","article-title":"Current understanding of IL-37 in human health and disease.","volume":"12","author":"Su","year":"2021","journal-title":"Front. Immunol."},{"key":"B63","first-page":"1962","article-title":"Agents of mucormycosis and related species","author":"Sugar","year":"1990","journal-title":"Principles And Practice Of Infectious Diseases"},{"key":"B64","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.clim.2006.05.015","article-title":"Reduced IFN-\u03b1 secretion by blood dendritic cells in human diabetes.","volume":"121","author":"Summers","year":"2006","journal-title":"Clin. Immunol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity.","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2014.00762","article-title":"Protective host defense against disseminated candidiasis is impaired in mice expressing human interleukin-37.","volume":"7","author":"van de Veerdonk","year":"2015","journal-title":"Front. Microbiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13054-020-03400-9","article-title":"Corticosteroid use in COVID-19 patients: a systematic review and meta-analysis on clinical outcomes.","volume":"24","author":"van Paassen","year":"2020","journal-title":"Crit. Care"},{"key":"B68","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1007\/s11239-020-02270-w","article-title":"Markers of coagulation dysfunction and inflammation in diabetic and non-diabetic COVID-19.","volume":"51","author":"Varikasuvu","year":"2021","journal-title":"J. Thromb. Thrombolysis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1172\/JCI111395","article-title":"Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus.","volume":"74","author":"Waldorf","year":"1984","journal-title":"J. Clin. Invest."},{"key":"B70","doi-asserted-by":"publisher","first-page":"4711","DOI":"10.3892\/ol.2018.7982","article-title":"Interleukin-37: a crucial cytokine with multiple roles in disease and potentially clinical therapy.","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"B71","year":"2019","journal-title":"Classification Of Diabetes Mellitus."},{"key":"B72","year":"2020","journal-title":"No Title: Corticosteroids for COVID-19: Living Guidance, 2 September 2020."},{"key":"B73","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/ijo.2008.233","article-title":"Physiological and pathophysiological roles of adiponectin and adiponectin receptors in the integrated regulation of metabolic and cardiovascular diseases.","volume":"32","author":"Yamauchi","year":"2008","journal-title":"Int. J. Obes."},{"key":"B74","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes.","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol."},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.45134","article-title":"COVID-19: what has been learned and to be learned about the novel coronavirus disease.","volume":"16","author":"Yi","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1111\/all.14238","article-title":"Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.","volume":"75","author":"Zhang","year":"2020","journal-title":"Allergy"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.2337\/diabetes.49.9.1451","article-title":"Altered cytokine and nitric oxide secretion in vitro by macrophages from diabetic type II-like db\/db mice.","volume":"49","author":"Zykova","year":"2000","journal-title":"Diabetes"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.788741\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T08:13:47Z","timestamp":1667549627000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.788741\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,13]]},"references-count":77,"alternative-id":["10.3389\/fmicb.2021.788741"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.788741","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,13]]},"article-number":"788741"}}